Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
暂无分享,去创建一个
[1] J. Götz,et al. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation , 2017, The EMBO journal.
[2] J. Götz,et al. Tau-based therapies in neurodegeneration: opportunities and challenges , 2017, Nature Reviews Drug Discovery.
[3] J. Girault,et al. Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model , 2017, Nature Communications.
[4] K. Vossel,et al. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture , 2017, Molecular Neurodegeneration.
[5] D. Holtzman,et al. Elucidating the Role of TREM2 in Alzheimer’s Disease , 2017, Neuron.
[6] Wendy Noble,et al. Roles of tau protein in health and disease , 2017, Acta Neuropathologica.
[7] B. Hyman,et al. Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease , 2017, Synapse.
[8] D. Xia,et al. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment , 2017, Acta Neuropathologica.
[9] P. Reddy,et al. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. , 2016, Human molecular genetics.
[10] H. Soininen,et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.
[11] K. Vuori,et al. Novel Role of Src in Priming Pyk2 Phosphorylation , 2016, PloS one.
[12] R. Brandt,et al. Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease , 2016, Drugs.
[13] L. Buée,et al. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo , 2015, Neurobiology of Disease.
[14] M. Falasca,et al. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets. , 2015, The Biochemical journal.
[15] D. Xia,et al. Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. , 2015, Biochimica et biophysica acta.
[16] Matthew Schreiber,et al. Alzheimer’s Disease Genetics , 2014, Current Behavioral Neuroscience Reports.
[17] Margaret A. Pericak-Vance,et al. Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias , 2014, PLoS genetics.
[18] Manolis Kellis,et al. Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.
[19] D. Xia,et al. Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn , 2014, Front. Mol. Neurosci..
[20] M. Hemberg,et al. Tau promotes neurodegeneration through global chromatin relaxation , 2014, Nature Neuroscience.
[21] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[22] J. Götz,et al. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice , 2013, Neurobiology of Aging.
[23] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[24] D. Bennett,et al. The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease , 2012, The Journal of Neuroscience.
[25] A. Vortmeyer,et al. Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.
[26] S. Andrews,et al. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse , 2012, Neurobiology of Aging.
[27] L. Mucke,et al. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[28] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[29] M. Sheng,et al. Proline-Rich Tyrosine Kinase 2 Regulates Hippocampal Long-Term Depression , 2010, The Journal of Neuroscience.
[30] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[31] R. Salgia,et al. Fyn: a novel molecular target in cancer. , 2010, Cancer.
[32] J. Hell,et al. Postsynaptic Clustering and Activation of Pyk2 by PSD-95 , 2010, The Journal of Neuroscience.
[33] C. Lipinski,et al. Targeting Pyk2 for therapeutic intervention , 2010, Expert opinion on therapeutic targets.
[34] J. Götz,et al. Divergent phosphorylation pattern of tau in P301L tau transgenic mice , 2008, The European journal of neuroscience.
[35] R. Geahlen,et al. The microtubule-associated protein tau is phosphorylated by Syk , 2008, Biochimica et biophysica acta.
[36] Jürgen Götz,et al. Pronuclear injection for the production of transgenic mice , 2007, Nature Protocols.
[37] K. Ashe,et al. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy , 2007, The Journal of Neuroscience.
[38] S. Yen,et al. Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.
[39] Wendy Noble,et al. Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase , 2005, The Journal of Neuroscience.
[40] Feng Chen,et al. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. , 2004, Current drug targets.
[41] G. V. Van Hoesen,et al. Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[42] G. Rodan,et al. PYK2 Autophosphorylation, but Not Kinase Activity, Is Necessary for Adhesion-induced Association with c-Src, Osteoclast Spreading, and Bone Resorption* , 2003, The Journal of Biological Chemistry.
[43] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[44] J. Roder,et al. CAKβ/Pyk2 Kinase Is a Signaling Link for Induction of Long-Term Potentiation in CA1 Hippocampus , 2001, Neuron.
[45] H. Band,et al. Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.
[46] S. Lev,et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.
[47] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] Keith A. Johnson,et al. Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes , 2016 .
[49] G. Eckert,et al. Mitochondrial dysfunction: cause and consequence of Alzheimer's disease. , 2014, Progress in molecular biology and translational science.